People under the age of 40 in the U.K. are to be offered an alternative to the Oxford-AstraZeneca Covid-19 vaccine, as concerns over links to rare blood clots continue to weigh on its roll out. Speaking at a press conference on Friday, Professor Wei Shen Lim, chair of the U.K.’s Joint Committee on Vaccination and […] Read more